Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmoset

Effective antiviral treatments for MERS-CoV are urgently needed. LCA60 is a MERS-CoV-neutralizing monoclonal antibody isolated from a convalescent MERS patient. Previously, it was shown that treatment with LCA60 resulted in reduced disease and virus titers in mouse models of MERS-CoV infection. Here...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antiviral Res
Hauptverfasser: de Wit, Emmie, Feldmann, Friederike, Horne, Eva, Okumura, Atsushi, Cameroni, Elisabetta, Haddock, Elaine, Saturday, Greg, Scott, Dana, Gopal, Robin, Zambon, Maria, Corti, Davide, Feldmann, Heinz
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7113761/
https://ncbi.nlm.nih.gov/pubmed/30684561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2019.01.016
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge